John L. Flavin named president of Advanced Life Sciences

Woodridge, Ill, August 3, 2004 - John L. Flavin has assumed the role of president of Advanced Life Sciences (ALS) of Woodridge, IL. He joined ALS in June 2002 as chief financial officer and was elected to its Board of Directors in 2003.

“We’re very proud of the breakthrough work we’ve been doing at Advanced Life Sciences,” said Flavin. “The drugs we are developing in the areas of infectious disease, oncology and inflammation are very promising and are targeted to meet significant unmet medical needs.”

Flavin is recognized for his experience in company building, public and private financing initiatives, and mergers and acquisitions. He is the former chief operating officer and director of Woodridge-based MediChem Life Sciences, Inc. where he was responsible for the chemistry-based drug discovery company’s business and scientific operations.

Flavin helped lead each of MediChem’s capital financings and was responsible for establishing and growing many of the key collaborations with MediChem’s blue-chip pharmaceutical and biotechnology partners. He also served as chief executive officer of MediChem’s protein engineering and proteomics subsidiaries, Emerald BioStructures, ThermoGen and AXAS.

Flavin holds a Bachelor of Science degree in Business Administration from Marquette University in Milwaukee and an Masters in Business Administration from Lewis University in Romeoville, IL.

Advanced Life Sciences is a privately held biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation using its platform in natural products and chemical proteomics coupled with expertise in drug development. (